tirzepatide and afib GLP-1 receptor agonists, including semaglutide (Wegovy/Ozempic) (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in 🧠Let's break the drug tirzepatide

The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk's blockbuster obesity and diabetes drugs Wegovy and Ozempic

Revisiting intensive blood glucose control: a causal directed acyclic graph-guided systematic review of randomized controlled trials

1 Mater Research Institute, The University of Queensland, Brisbane, Australia, 2 Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, Australia, 3 Department of Medicine, The University of Melbourne, Austin health, Melbourne, Australia

cGMP-elevating compounds and ischemic conditioning provide cardioprotection against ischemia and reperfusion injury via cardiomyocyte-specific BK channels

For patients experiencing diarrhea or abdominal discomfort, morning administration may be preferable, as it allows symptoms to manifest during daytime hours when patients have easier access to bathroom facilities and can manage hydration more effectively